/Tag:InterveXion

UAMS Saw Transformative Growth in 2015

Dec. 28, 2015 | UAMS experienced a year of growth and transformation  in 2015 that reached all areas of patient care, education and research. During this time of development, UAMS saw many changes in leadership. In January, Jeanne Heard, M.D., Ph.D., announced her retirement as provost effective June 30 after more forty years at UAMS. [...]

By | December 28th, 2015|University News|0 Comments

InterveXion and UAMS Complete First Drug Tests in Humans for Methamphetamine Addiction

LITTLE ROCK – InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.

By | December 19th, 2012|Media Contact - Taylor/Peel, UAMS News|0 Comments

First Human Tests of Meth Medication Completed

Dec. 19, 2012 | InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.

By | December 19th, 2012|UAMS News, University News|0 Comments